These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6703681

  • 1. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers.
    Greenman RL, Arcey SM, Gutterman DA, Zweig RM.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):16-9. PubMed ID: 6703681
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis.
    Cooper RH, Savitch CB, Joseph WP, Mills J.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):256-9. PubMed ID: 7347561
    [Abstract] [Full Text] [Related]

  • 3. Cephapirin therapy in infective endocarditis.
    Burch KH, Quinn EL, Saravolatz LD, Madhavan T, Jovanovich JF, Pohlod D.
    South Med J; 1983 Apr; 76(4):448-52. PubMed ID: 6836358
    [Abstract] [Full Text] [Related]

  • 4. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of ceforanide in the treatment of childhood infections.
    Thirumoorthi MC, Buckley JA, Vincent CV, Kobos D, Dajani AS.
    Pediatr Infect Dis; 1983 Oct; 2(5):377-80. PubMed ID: 6634466
    [Abstract] [Full Text] [Related]

  • 6. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
    Wallace RJ, Martin RR, Quinones FJ, Greenberg SB.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):648-52. PubMed ID: 7034641
    [Abstract] [Full Text] [Related]

  • 7. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF, Mills J, Drake TA, Sande MA.
    Rev Infect Dis; 1984 Nov; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [Abstract] [Full Text] [Related]

  • 8. Ceforanide: in vitro and clinical evaluation.
    Burch KH, Pohlod D, Saravolatz LD, Madhavan T, Kiani D, Quinn EL, Del Busto R, Cardenas J, Fisher EJ.
    Antimicrob Agents Chemother; 1979 Sep; 16(3):386-91. PubMed ID: 507795
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ceforanide.
    Ripa S, La Rosa F, Ghezzi A, Prenna M, Pfeffer M.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents.
    Dajani AS, Thirumoorthi MC, Bawdon RE, Buckley JA, Pfeffer M, Van Harken DR, Smyth RD.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):282-7. PubMed ID: 7073266
    [Abstract] [Full Text] [Related]

  • 11. In vitro and clinical evaluation of ceforanide.
    Lefrock JL, Holloway W, Carr BB, Schell RF.
    Am J Med Sci; 1984 Feb; 287(2):21-5. PubMed ID: 6711584
    [Abstract] [Full Text] [Related]

  • 12. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers.
    Abrams B, Sklaver A, Hoffman T, Greenman R.
    Ann Intern Med; 1979 May; 90(5):789-91. PubMed ID: 434682
    [Abstract] [Full Text] [Related]

  • 13. Treatment of pneumonia and other serious bacterial infections with cephapirin.
    Robson HG, Bowmer MI.
    Antimicrob Agents Chemother; 1974 Sep; 6(3):274-81. PubMed ID: 15830473
    [Abstract] [Full Text] [Related]

  • 14. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
    Chambers HF, Miller RT, Newman MD.
    Ann Intern Med; 1988 Oct 15; 109(8):619-24. PubMed ID: 3421575
    [Abstract] [Full Text] [Related]

  • 15. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers.
    Fortún J, Pérez-Molina JA, Añón MT, Martínez-Beltrán J, Loza E, Guerrero A.
    Antimicrob Agents Chemother; 1995 Feb 15; 39(2):525-8. PubMed ID: 7726526
    [Abstract] [Full Text] [Related]

  • 16. Human pharmacokinetics of a new braod-spectrum parenteral cephalosporin antibiotic, ceforanide.
    Pfeffer M, Gaver RC, Van Harken DR.
    J Pharm Sci; 1980 Apr 15; 69(4):398-403. PubMed ID: 7373533
    [Abstract] [Full Text] [Related]

  • 17. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM, Lackner TE, Monk JP.
    Drugs; 1987 Oct 15; 34(4):411-37. PubMed ID: 3315624
    [Abstract] [Full Text] [Related]

  • 18. Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview.
    Mader JT, Reinarz JA.
    Rev Infect Dis; 1984 Oct 15; 6 Suppl 4():S857-64. PubMed ID: 6395277
    [Abstract] [Full Text] [Related]

  • 19. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA, Buck RE, Price KE, Leitner F.
    J Antibiot (Tokyo); 1979 Jul 15; 32(7):727-33. PubMed ID: 396292
    [Abstract] [Full Text] [Related]

  • 20. Bacterial endocarditis treated with intramuscular teicoplanin.
    Chauhan S, D'Cruz S, Sachdev A, Singh R.
    Singapore Med J; 2007 Sep 15; 48(9):e248-9. PubMed ID: 17728952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.